Embracing Future Holdings Limited (SGX:8YY)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0510
0.00 (0.00%)
At close: Apr 28, 2026
155.00%
Market Cap 88.41M
Revenue (ttm) 5.26M
Net Income (ttm) -3.96M
Shares Out 1.73B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,160,300
Average Volume 5,687,925
Open 0.0510
Previous Close 0.0510
Day's Range 0.0500 - 0.0520
52-Week Range 0.0190 - 0.0920
Beta 0.68
RSI 40.40
Earnings Date May 6, 2026

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 b... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 16
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 8YY
Full Company Profile

Financial Performance

In 2025, Embracing Future Holdings's revenue was 5.26 million, an increase of 513.17% compared to the previous year's 858,000. Losses were -3.96 million, 15.4% more than in 2024.

Financial Statements

News

There is no news available yet.